Thomas Jefferson University

Jefferson Digital Commons
Department of Family & Community Medicine
Faculty Papers

Department of Family & Community Medicine

1-1-2013

Advancing maternal survival in the global context: are our
strategies working?
Omar A Khan
Thomas Jefferson University

Richard Derman
Christiana Care Health System

Nancy L Sloan
Christiana Care Health System

Follow this and additional works at: https://jdc.jefferson.edu/fmfp
Part of the Family Medicine Commons

Let us know how access to this document benefits you
Recommended Citation
Khan, Omar A; Derman, Richard; and Sloan, Nancy L, "Advancing maternal survival in the global
context: are our strategies working?" (2013). Department of Family & Community Medicine
Faculty Papers. Paper 39.
https://jdc.jefferson.edu/fmfp/39
This Article is brought to you for free and open access by the Jefferson Digital Commons. The Jefferson Digital
Commons is a service of Thomas Jefferson University's Center for Teaching and Learning (CTL). The Commons is
a showcase for Jefferson books and journals, peer-reviewed scholarly publications, unique historical collections
from the University archives, and teaching tools. The Jefferson Digital Commons allows researchers and interested
readers anywhere in the world to learn about and keep up to date with Jefferson scholarship. This article has been
accepted for inclusion in Department of Family & Community Medicine Faculty Papers by an authorized
administrator of the Jefferson Digital Commons. For more information, please contact:
JeffersonDigitalCommons@jefferson.edu.

Khan et al. BMC Public Health 2013, 13:689
http://www.biomedcentral.com/1471-2458/13/689

COMMENTARY

Open Access

Advancing maternal survival in the global
context: are our strategies working?
Omar A Khan1,2*, Richard Derman3 and Nancy L Sloan4

Abstract
There have been significant gains in improving maternal mortality over the last two decades. Researchers have
suggested a variety of interventions and mechanisms to explain these improvements. While it is likely that much of
what has been done in research and programs has contributed to this decline, the evidence regarding what works
in the settings in which women deliver continues to face many challenges. We review the evidence for these
improvements and suggest that there remain areas to focus on, particularly the births which currently take place in
an unsupervised or substandard environments. We highlight the main areas where more evidence is needed, and
end with a call to determine which of our interventions seem to have the most benefit; which do not; and where
to invest future resources.
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Background
There have been great advances in maternal survival between 1990 and 2010 [1]. In 1990, the WHO estimated
543,000 women each year experienced pregnancy-related
deaths, and declined to 287,000 by 2010, 99% of which
occur in developing countries. This trend is supported by
other estimates [2]. Theories have been proposed to explain these achievements [3]; but the theories may or may
not be based upon sound research, and unaddressed issues
remain [4-6].
Main text
What we do know is that many maternal deaths occur
because they are not receiving timely, quality intervention [1,2,7]. Unlike hospital settings that provide quality
services, many women, including some of those delivering at home or at institutions providing substandard
care, do not receive the benefits of appropriate management. This may include provision of additional uterotonics,
manual removal of the placenta, hysterectomy and/or
transfusion for continued postpartum bleeding, Caesarean
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section for dysfunctional labor, magnesium sulfate for eclampsia, antibiotic treatment for infection and nutritional
supplementation.
The questions about what caused the improvements in
maternal survival are justifiable. Many have argued they
are due simply to improving skilled birth attendance or
institutional deliveries, even in settings where such attendance often cannot or does not provide the essential
obstetric management required [8,9]. However, provision
of skilled attendance alone, outside the institutional
setting, has proven less effective than hoped [10], while
quality improvement mechanisms have accomplished
great achievements in institutional service provision
[11-13]. Management without sufficient or adequately
trained personnel, medication and infrastructural resources,
much less a hygienic environment, may not effectively
manage some or many of the conditions that cause maternal mortality [14].
Improving many factors may be necessary, such as
permitting community-based attendants to provide oxytocin injections to prevent postpartum hemorrhage, and
agents such as misoprostol that effectively prevent postpartum hemorrhage [15]. Improving the continuum of
care and timely use of institutional care may require
roads, transportation, better education and the desirability of care (including its quality) all of which may require
economic development and societal beneficence [16].
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Improving the quality of care requires more than
supplies, equipment and training, but also requires establishing processes that integrate understanding patients
needs, engagement of health providers, monitoring and
reviewing data regarding how care processes function
within the delivery system, and ongoing modification of
both the processes and the systems to improve care and
outcomes [12,17].

Discussion
The knowledge gap: (not) knowing what works

Millions of dollars have been spent over the past decades
to improve maternal survival, yet we still do not know if
the observed improvements are attributable to the interventions we are conducting, or due to other factors, such
as additional supportive services and/or overall economic
improvement12. Ten years ago, we suggested that it would
be necessary and wise to directly assess the impact of our
interventions on maternal mortality rather than solely
evaluating surrogate measures [18]. For years, the conventional wisdom held that measuring maternal mortality was
just too difficult and expensive [19]. In our efforts to improve infant survival, it took decades to recognize that
prematurity and infection were the major etiology of most
infant mortality in low birth weight babies and that efforts
solely to improve caloric intake were ineffective in improving survival [20]. Similarly, it has taken decades to
suggest that measuring maternal mortality may be necessary and is worthwhile [13,21].
Only a handful of methodologically sound studies to
demonstrate the effectiveness of priority interventions delivered in substandard environments have been conducted
[22-24]. The NIPPS study that found vitamin A supplementation nearly halved maternal mortality rates in Nepal
(in a setting with a high prevalence of moderate-severe
vitamin A deficiency) was met with great controversy.
Arguments were made that the reported causes of death
were not coherent, even though the causes of death were
reported as symptoms by lay people, relatives of the deceased in an area where illiteracy is common and medical
diagnostic capacity is virtually absent [25]. A large replication trial was conducted in rural Ghana, in an area where
the consumption of red palm oil is common, with the
stated objective of disproving that vitamin A supplementation could reduce maternal mortality [26]. As with a replication study conducted in Bangladesh [27], however, the
low prevalence of moderate-severe vitamin A deficiency
undercut the studies’ potential to find an association
between supplementation and survival. An extremely large
study, but with inadequate and incomplete measurement
of the outcome variable, child mortality, proposes to
overturn policies and programs that have saved millions
of children’s lives [28,29]. Some have proposed that
the millions spent on programs to prevent postpartum
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hemorrhage have significantly reduced maternal mortality,
yet this has not been directly assessed by rigorous research
in the settings where there is substandard access to and/or
quality of care, where most maternal mortality occurs
[30]. The fact that uterotonics are more effective at
preventing high levels of blood loss supports the notion
that their provision may be preventing maternal mortality24. However, we still do not know if the women who
actually die of postpartum hemorrhage are those with extremely high levels of blood loss caused by conditions
other than uterine atony for which uterotonics may be
relatively ineffective and for which other intervention,
such as transfusion and/or, hysterectomy are required. In
addition, in these developing country, we still do not know
if individual interventions alone such as vitamin A supplementation would improve maternal survival in Niger
or Afghanistan, where the prevalence of moderate-severe
vitamin A deficiency and maternal mortality rates remain
high, nor the answers to other important questions such
as whether a loading dose of magnesium sulfate provided
in a community-based setting will improve mortality from
eclampsia.
The next steps

We know that the expense and complexity of measuring
maternal mortality has hindered our efforts to conduct
the rigorous research necessary to determine if our interventions are saving women’s lives in settings where
care is substandard; and if so, to what extent and how.
Household surveillance systems are excellent mechanisms to support research, yet are not the sole means
necessary to achieve nearly universal vital events
reporting [31]. While household surveillance systems
have benefits beyond accurate reporting, including
bringing jobs, improving the local economy, and even
nutritional status[32-34], household surveys can provide
accurate, complete reporting, and with adequate training, supervision and supplies, validated mobile device
reporting may become an option [35,36]. Such techniques can allow us to affordably and accurately measure
impact on maternal mortality. Whether as researchers,
program managers, or donors, we need to rise to the
challenge of strengthening (or in some cases, creating)
the evidence base to assess our programs.

Conclusion
We have started asking the question, ‘what do we know’?
The answer seems to be ‘less than we think we do’. We
suggest that along with doing what we think makes a
difference, we need to confirm it and if necessary,
change it. We suggest that, above and beyond monitoring and evaluation, rigorous research is necessary to
measure the impact of the interventions we promote for
scale up on the theory that they may prevent maternal
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mortality in settings where women typically receive
substandard care to understand if they are indeed effective in such settings without coexistent improvement of
supportive care. It is critical to determine whether and
which of our interventions improves maternal survival
in settings with substandard care, and thus reduce maternal mortality where most of it continues to occur.
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